Cargando…

A vaccine for SARS-CoV-2: goals and promises

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387929/ https://www.ncbi.nlm.nih.gov/pubmed/32766547 http://dx.doi.org/10.1016/j.eclinm.2020.100494

Ejemplares similares

SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
por: Baldo, Vincenzo, et al.
Publicado: (2021)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

In Pursuit of a SARS-CoV-2 Vaccine
por: Johnson, Alton R., et al.
Publicado: (2020)

SARS-CoV2 vaccines: Slow is fast
por: Green, Douglas R.
Publicado: (2020)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022)

The SARS-CoV-2 vaccines: Retrospective and perspectives
por: Epaulard, Olivier
Publicado: (2022)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

SARS-CoV-2 Vaccination for Children—An Open Issue
por: Caselli, Désirée, et al.
Publicado: (2021)

Vaccination for SARS-CoV-2 of migrants and refugees, Jordan
por: Bellizzi, Saverio, et al.
Publicado: (2021)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
por: Morris, Kevin V.
Publicado: (2020)

Influenza vaccination in the time of SARS-CoV-2()
por: Reina, Jordi
Publicado: (2021)

Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
por: Kremer, Eric J.
Publicado: (2020)

Commentary on ‘Will vaccination refusal prolong the war on SARS-CoV-2?’
por: Welsby, Philip D
Publicado: (2020)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021)

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

A promising inactivated whole-virion SARS-CoV-2 vaccine
por: Isakova-Sivak, Irina, et al.
Publicado: (2021)

Vaccination against SARS-CoV-2 should be included in childhood vaccination programs
por: Petersen, Eskild, et al.
Publicado: (2021)

Realising the potential of SARS-CoV-2 vaccines—a long shot?
por: The Lancet Respiratory Medicine
Publicado: (2021)

SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?
por: Krueger, Karen M., et al.
Publicado: (2022)

A Brief Focus on SARS-CoV-2 Genomic Evolution and Vaccines
por: Pratelli, Annamaria, et al.
Publicado: (2023)

Current vaccine strategies against SARS-CoV-2: Promises and challenges
por: Kurup, Drishya, et al.
Publicado: (2022)

A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
por: Chavda, Vivek P, et al.
Publicado: (2021)

SARS-CoV-2 docet
por: Sarli, Leopoldo
Publicado: (2021)

Can an effective SARS-CoV-2 vaccine be developed for the older population?
por: Pawelec, Graham, et al.
Publicado: (2020)

SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention
por: Rubin, Eric J., et al.
Publicado: (2020)

Impact of spike genetic variants in vaccines against SARS-CoV-2()
por: Reina, J., et al.
Publicado: (2021)

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
por: Parums, Dinah V.
Publicado: (2021)

SARS-CoV-2 vaccination should be required to practise medicine in Canada
por: McRae, Andrew D., et al.
Publicado: (2021)

Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer
por: Chebel, Roy, et al.
Publicado: (2021)

SARS-CoV-2 Vaccination: What Can We Expect Now?
por: Meurens, François, et al.
Publicado: (2022)

Author Correction: Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

Similarity between cutaneous reactions due to SARS-CoV-2 and its vaccinations
por: Kutlu, Ömer, et al.
Publicado: (2022)

Is the Patient Infected with SARS-CoV-2?
por: Klausner, Jeffrey D., et al.
Publicado: (2021)

Fundamentals of SARS-CoV-2 Biosensors
por: Torres-Torres, Carlos, et al.
Publicado: (2022)

Terrific cells for SARS-CoV-2
por: Gottschalk, Stephen
Publicado: (2022)

A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
por: Jo, Seri, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lpos5o38msicj5b05eukgmspea